Skip to main content

Prestigious European CAR-T cell manufacturing plant of J&J lands in Ghent embedded in the thriving Belgium/Flanders ecosystem.

Janssen will produce innovative cell therapies in Belgium. The Tech Lane Science Park in Ghent will be the location of Janssen's first European state-of-the-art facilities for the production of CAR-T therapy. The facilities are being developed in cooperation with Legend Biotech to enable the future production and supply of CAR-T therapy for the treatment of certain types of cancer in Europe.

View the full article on the website...